BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29978449)

  • 21. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.
    Houthuijzen JM; Jonkers J
    Cancer Metastasis Rev; 2018 Dec; 37(4):577-597. PubMed ID: 30465162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Missed Druggable Cancer Hallmark: Cancer-Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy.
    Sverdlov E
    Bioessays; 2018 Nov; 40(11):e1800079. PubMed ID: 30188575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of tumor microenvironment by chemopreventive natural products.
    Park SA; Surh YJ
    Ann N Y Acad Sci; 2017 Aug; 1401(1):65-74. PubMed ID: 28640929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of inflammation in progression of breast cancer: Friend or foe? (Review).
    Allen MD; Jones LJ
    Int J Oncol; 2015 Sep; 47(3):797-805. PubMed ID: 26165857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remodeling the Microenvironment before Occurrence and Metastasis of Cancer.
    Zhang X; Xiang J
    Int J Biol Sci; 2019; 15(1):105-113. PubMed ID: 30662351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RISING STARS: Hormonal regulation of the breast cancer microenvironment.
    Boyle ST
    J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36629385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory fibroblasts in cancer.
    Lim H; Moon A
    Arch Pharm Res; 2016 Aug; 39(8):1021-31. PubMed ID: 27384063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
    J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology.
    Burks H; Pashos N; Martin E; Mclachlan J; Bunnell B; Burow M
    Mol Cell Endocrinol; 2017 Dec; 457():13-19. PubMed ID: 28012841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cancer-associated fibroblasts in breast cancer pathobiology.
    Jung YY; Kim HM; Koo JS
    Histol Histopathol; 2016 Apr; 31(4):371-8. PubMed ID: 26627101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients.
    Chan MS; Wang L; Felizola SJ; Ueno T; Toi M; Loo W; Chow LW; Suzuki T; Sasano H
    Int J Biol Markers; 2012 Dec; 27(4):e295-304. PubMed ID: 23280127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma's connections to the tumour microenvironment.
    Brandner JM; Haass NK
    Pathology; 2013 Aug; 45(5):443-52. PubMed ID: 23851614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of tumor microenvironment in the progression of oral cancer.
    Patil S; Rao R; Raj T
    J Contemp Dent Pract; 2015 Mar; 16(3):i-ii. PubMed ID: 26057928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated adipocytes: key players in breast cancer progression.
    Wu Q; Li B; Li Z; Li J; Sun S; Sun S
    J Hematol Oncol; 2019 Sep; 12(1):95. PubMed ID: 31500658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model.
    Meng M; Wang W; Yan J; Tan J; Liao L; Shi J; Wei C; Xie Y; Jin X; Yang L; Jin Q; Zhu H; Tan W; Yang F; Hou Z
    Tumour Biol; 2016 Aug; 37(8):10317-27. PubMed ID: 26842926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
    González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
    Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Maggiolini M
    J Steroid Biochem Mol Biol; 2018 Feb; 176():49-56. PubMed ID: 28249728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.